Off-Label: Why Drugs Like Ivermectin Spark Debate
Off-label use refers to the practice of prescribing a medication for a purpose, dosage, patient group, or form of administration that has not been approved by the FDA.
Entries by Kristen Sterzinger, CPhT
Understanding Spravato® Strict Delivery Requirements
Spravato® (esketamine) is a prescription nasal spray approved for treatment-resistant depression (TRD) and major depressive disorder (MDD) with suicidal thoughts. Due to its potential for misuse and serious side effects, Spravato® is subject to strict handling, administration, and monitoring requirements under the FDA’s Risk Evaluation and Mitigation Strategy (REMS).
Reap the Benefits of the PAAS National® Newsline Archive
Did you know that you can save time by searching past Newsline articles to find answers to your common questions? In fact, the Newsline archive offers articles going back to 2016! The search feature makes it simple to find that one article you know you read a while ago, but can’t seem to remember what […]
How to Submit Your Audit Documents for an Effective Review
PAAS National® analysts continue to see an increasing amount of PBM audits demanding large audit volumes of documents for reviews.
Caremark® Continues to Recover Payments for Unapproved Coupons
PAAS National® continues to see pharmacies face full recoupment on claims that are processed to coupons and copay cards in violation of Caremark’s® policy found in section 3.03.03 of the 2024 Pharmacy Provider Manual.
Are PBM Regulations Being Enforced by Your State? Let Your Voice Be Heard!
When PBMs violate state law, pharmacies need to scream from the mountain tops. Get the ball rolling by filing a complaint with your state regulators.
Do I Need to Consider Beyond Use Dating for Multi-dose Vial Medication?
The answer is YES! Multi-Dose Vials (MDV) for injection have Beyond Use Dates (BUD) that need to be followed.
